Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
Mario Luca MorieriValentina PerroneChiara VeronesiLuca Degli EspostiMargherita AndrettaMario PlebaniGian Paolo FadiniSaula Vigili de KreutzenbergAngelo AvogaroPublished in: Cardiovascular diabetology (2021)
Among patients on statin treatment and high adherence, only a small proportion of patients achieved LDL-cholesterol targets. Late initiation of high-intensity treatments, particularly among those with misperceived low-risk (e.g., female subjects or those with high HDL-cholesterol), appears as pivotal factors needing to be modified to improve CVD prevention.
Keyphrases
- low density lipoprotein
- high intensity
- type diabetes
- end stage renal disease
- cardiovascular disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- resistance training
- glycemic control
- coronary artery disease
- prognostic factors
- peritoneal dialysis
- adipose tissue
- patient reported outcomes
- insulin resistance